UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Blood, 2010-04, Vol.115 (17), p.3520-3530

2010

Volltextzugriff (PDF)

Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors

Molecular cancer therapeutics, 2010-02, Vol.9 (2), p.489-498

2010

Volltextzugriff (PDF)

OLINDA/EXM: The Second-Generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine

The Journal of nuclear medicine (1978), 2005-06, Vol.46 (6), p.1023

2005

Volltextzugriff (PDF)

INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support

Neoplasia (New York, N.Y.), 2010-01, Vol.12 (1), p.28-38

2010

Volltextzugriff (PDF)

First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [ 68 Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Journal of Nuclear Medicine, 2024-05, Vol.65 (5), p.740-743

2024

Volltextzugriff (PDF)

Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B

The Journal of biological chemistry, 2006-12, Vol.281 (49), p.38013-38021

2006

Volltextzugriff (PDF)

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Critical reviews in oncology/hematology, 2001-07, Vol.39 (1), p.181-194

2001

Volltextzugriff (PDF)

Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity

Clinical cancer research, 2009-11, Vol.15 (22), p.6891-6900

2009

Volltextzugriff (PDF)

Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

Cancer, 2002-02, Vol.94 (S4), p.1349-1357

2002

Volltextzugriff (PDF)

INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3‑Kinase Delta (PI3Kδ)

ACS medicinal chemistry letters, 2019-11, Vol.10 (11), p.1554-1560

2019

Volltextzugriff (PDF)

Microwave-Assisted Synthesis of 2,4,5-Triaryl-imidazole; A Novel Thermally Induced N-Hydroxyimidazole N−O Bond Cleavage

Organic letters, 2004-07, Vol.6 (14), p.2473-2475

2004

Volltextzugriff (PDF)

Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic (S)-Isothiazolidinone Phosphotyrosine Mimetic

Journal of medicinal chemistry, 2006-06, Vol.49 (13), p.3774-3789

2006

Volltextzugriff (PDF)

Mild Conversion of Esters Lacking Acidic α-Hydrogens into Amides via Samarium(III) Tris[hexamethyldisilazide] and Amines

Synlett, 2011-02, Vol.2011 (3), p.357-360

2011

Volltextzugriff (PDF)

Benzothiazole benzimidazole ( S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (3), p.736-740

2007

Volltextzugriff (PDF)

Calculating the Absorbed Dose from Radioactive Patients: The Line-Source Versus Point-Source Model

The Journal of nuclear medicine (1978), 2002-09, Vol.43 (9), p.1241-1244

2002

Volltextzugriff (PDF)

Red Marrow Radiation Dose Adjustment Using Plasma FLT3-L Cytokine Levels: Improved Correlations Between Hematologic Toxicity and Bone Marrow Dose for Radioimmunotherapy Patients

The Journal of nuclear medicine (1978), 2003-01, Vol.44 (1), p.67-76

2003

Volltextzugriff (PDF)

Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials

Human gene therapy, 2007-04, Vol.18 (4), p.312-322

2007

Volltextzugriff (PDF)

Blood-based red marrow dosimetry: where's the beef?

The Journal of nuclear medicine (1978), 2005-08, Vol.46 (8), p.1404-6; author reply 1405-6

2005

Volltextzugriff (PDF)

First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, 68GaGa-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

The Journal of nuclear medicine (1978), 2024-02

2024

Volltextzugriff (PDF)

Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity

The Journal of nuclear medicine (1978), 2002-08, Vol.43 (8), p.1110

2002

Volltextzugriff (PDF)

Sensitivity of model-based calculations of red marrow dosimetry to changes in patient-specific parameters

Cancer biotherapy & radiopharmaceuticals, 2002-10, Vol.17 (5), p.535-543

2002

Volltextzugriff (PDF)

Total-body and red marrow dose estimates

The Journal of nuclear medicine (1978), 2003-02, Vol.44 (2), p.320

2003

Volltextzugriff (PDF)

Radioactivity appearing at landfills in household trash of nuclear medicine patients: much ado about nothing?

Health physics (1958), 2002-03, Vol.82 (3), p.367-372

2002

Volltextzugriff (PDF)

Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia

Cancer biotherapy & radiopharmaceuticals, 2003-04, Vol.18 (2), p.165-178

2003

Volltextzugriff (PDF)

(S)-4-(3-^sup 18^F-Fluoropropyl)-l-Glutamic Acid: An ^sup 18^F-Labeled Tumor-Specific Probe for PET/CT Imaging - Dosimetry

The Journal of nuclear medicine (1978), 2013-06, Vol.54 (6), p.861

2013

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Englisch
(185)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Life Sciences & Biomedicine
(90)
Humans
(67)
Biological And Medical Sciences
(38)
Female
(37)
Male
(35)
Medical Sciences
(28)
Adult
(24)
Middle Aged
(20)
Physical Sciences
(19)
Animals
(17)
Radiology, Nuclear Medicine & Medical Imaging
(16)
Aged
(14)
Fundamental And Applied Biological Sciences. Psychology
(13)
Adolescent
(11)
Cardiovascular System & Cardiology
(10)
Chemistry
(10)
Child
(10)
Environmental Sciences & Ecology
(10)
Pharmacology & Pharmacy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors

OLINDA/EXM: The Second-Generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine

INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support

First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [ 68 Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity

Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3‑Kinase Delta (PI3Kδ)

Microwave-Assisted Synthesis of 2,4,5-Triaryl-imidazole; A Novel Thermally Induced N-Hydroxyimidazole N−O Bond Cleavage

Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic (S)-Isothiazolidinone Phosphotyrosine Mimetic

Mild Conversion of Esters Lacking Acidic α-Hydrogens into Amides via Samarium(III) Tris[hexamethyldisilazide] and Amines

Benzothiazole benzimidazole ( S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors

Calculating the Absorbed Dose from Radioactive Patients: The Line-Source Versus Point-Source Model

Red Marrow Radiation Dose Adjustment Using Plasma FLT3-L Cytokine Levels: Improved Correlations Between Hematologic Toxicity and Bone Marrow Dose for Radioimmunotherapy Patients

Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials

Blood-based red marrow dosimetry: where's the beef?

First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, 68GaGa-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity

Sensitivity of model-based calculations of red marrow dosimetry to changes in patient-specific parameters

Total-body and red marrow dose estimates

Radioactivity appearing at landfills in household trash of nuclear medicine patients: much ado about nothing?

Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia

(S)-4-(3-^sup 18^F-Fluoropropyl)-l-Glutamic Acid: An ^sup 18^F-Labeled Tumor-Specific Probe for PET/CT Imaging - Dosimetry

Suchergebnisse filtern